Live News EQUITY FLASH L impact Oct 26, 2026, 11:34 AM UTC Biohaven’s BHV-1420 Cuts Anti-PLA2R Antibodies by More Than 90% in Mice Biohaven said BHV-1420 reduced anti-PLA2R antibodies by more than 90% in a mouse study. BHVN SquawkNews Desk